--- title: "CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/285939883.md" description: "CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News" datetime: "2026-05-11T04:15:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285939883.md) - [en](https://longbridge.com/en/news/285939883.md) - [zh-HK](https://longbridge.com/zh-HK/news/285939883.md) generator: "portal-rs" --- # CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News ### Related Stocks - [CERO.US](https://longbridge.com/en/quote/CERO.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [CEROW.US](https://longbridge.com/en/quote/CEROW.US.md) ## Related News & Research - [SRX Global buys senior secured debt in CERo Therapeutics Holdings](https://longbridge.com/en/news/297829391.md) - [SRX Global buys senior secured debt in CERo Therapeutics Holdings](https://longbridge.com/en/news/297509635.md) - [CERo Therapeutics Secures Up to $11.67 Million SRX Financing, Consolidates $5.67 Million Debt](https://longbridge.com/en/news/297561416.md) - [Cero Therapeutics signs SRX Global secured note for up to $11.67 million](https://longbridge.com/en/news/297560953.md) - [Grupa Azoty announces extraordinary shareholder meeting](https://longbridge.com/en/news/297635728.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**